Patricia Tsai MD in Woodland Hills, California

Home California Woodland Hills

Patricia Tsai MD has Ophthalmology as her primary medical specialty. Their primary office is: 5601 De Soto Ave in Woodland Hills, California.

They're a part of the: Southern California Permanente Medical Group medical group which has around 8,516 members. You can call their office at 818-719-2000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of California, San Francisco School Of Medicine and graduated in 1999 (around 25 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Patricia Tsai MD Office Phone and Directions

Patricia Tsai MD
Southern California Permanente Medical Group
5601 De Soto Ave
Woodland Hills, California 91367
818-719-2000

Patient Ratings
Please rate your experience with Patricia Tsai MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 818-719-2000

Enter a starting address:

Healthcare Info for Patricia Tsai MD

Medical School: University Of California, San Francisco School Of Medicine
Graduation Year: 1999
The Primary Medical Specialty for Patricia Tsai MD is listed as: Ophthalmology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 25
PAC (PECOS ID)#: 8325936792
NPI #: 1053470708
NPI Created On: 12/08/2006
NPI Last Updated Listed as: 12/03/2021
Primary Taxonomy Code: 207W00000X
License Number:
A73191
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 850376855

Being Disputed:: Yes

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Gastroenterology

Name of Drug #1: XIFAXAN

Open Associated Drug #1: 65649-303-02